Finland's Nightingale Health annual revenue rises on expansion of commercial team

Nightingale Health Oyj

16/09/2026 07:15

Overview
Finland blood test provider's annual revenue grew 17% yr/yr
Annual net loss and loss per share remained unchanged from prior year
Company expanded commercial operations, secured new contracts and received clinical lab permit in New York

Outlook
Nightingale Health targets revenue of at least EUR 10 mln for FY 2026–2027
Company will continue investing in international commercial operations in healthcare and research markets
Company does not expect to distribute a dividend in the short or medium term

Result Drivers
PROJECT DELAY - Co said revenue growth was limited by postponement of EUR 2.4 mln Denmark cohort study project, deferring about EUR 2 mln in revenue to next yr
SALES INVESTMENTS - Co said increased sales investments and expansion of commercial team contributed to revenue growth
NEW CONTRACTS - Co secured new agreements and launched pilot projects, helping drive customer interest and sales pipeline growth

Company press release: ID:nMFNbs7Mlh

Key Details
Metric
Beat/Miss
Actual
Consensus Estimate
FY Revenue
Miss
EUR 5.5 mln
EUR 6.60 mln (2 Analysts)
FY Loss Per Share
 
EUR 0.31
 
FY Net Loss
 
EUR 18.5 mln
 
FY EBITDA
 
-EUR 11.9 mln
 
FY Operating Income
 
-EUR 18.8 mln
 

Analyst Coverage
The one available analyst rating on the shares is "strong buy"
The average consensus recommendation for the biotechnology & medical research peer group is "buy."
Wall Street's median 12-month price target for Nightingale Health Oyj is €1.40, about 48% above its September 15 closing price of €0.95

Reuters Recommended Reads
Sept 15 - Finland set for higher growth, lower unemployment, central bank says

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)